These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6330386)

  • 41. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
    Brunell PA; Taylor-Wiedeman J; Geiser CF; Frierson L; Lydick E
    Pediatrics; 1986 Jan; 77(1):53-6. PubMed ID: 3455669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuated varicella virus vaccine in children with renal transplants.
    Zamora I; Simon JM; Da Silva ME; Piqueras AI
    Pediatr Nephrol; 1994 Apr; 8(2):190-2. PubMed ID: 8018498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy.
    Nunoue T
    Biken J; 1984 Sep; 27(2-3):115-8. PubMed ID: 6100047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live varicella vaccine in severely immunodepressed children.
    Ninane J; Latinne D; Heremans-Bracke MT; De Bruyere M; Cornu G
    Postgrad Med J; 1985; 61 Suppl 4():97-102. PubMed ID: 3014486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.
    Sugino H; Tsukino R; Miyashiro E; Dezawa T; Shinohara K; Uemura S; Koike M
    Biken J; 1984 Sep; 27(2-3):63-5. PubMed ID: 6100060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Live attenuated varicella vaccine.
    Gershon AA
    J Infect Dis; 1985 Nov; 152(5):859-62. PubMed ID: 2995509
    [No Abstract]   [Full Text] [Related]  

  • 48. The risk of zoster after varicella vaccination in children with leukemia.
    Lawrence R; Gershon AA; Holzman R; Steinberg SP
    N Engl J Med; 1988 Mar; 318(9):543-8. PubMed ID: 2828948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
    Nader S; Bergen R; Sharp M; Arvin AM
    J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status and prospects of live varicella vaccine.
    Takahashi M
    Vaccine; 1992; 10(14):1007-14. PubMed ID: 1335196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospects for use of a varicella vaccine in adults.
    Hardy IR; Gershon AA
    Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children.
    Asano Y; Takahashi M
    Pediatrics; 1977 Dec; 60(6):810-4. PubMed ID: 202916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.
    Watson B; Gupta R; Randall T; Starr S
    J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.
    Hughes P; LaRussa P; Pearce JM; Lepow M; Steinberg S; Gershon A
    J Pediatr; 1994 Jun; 124(6):932-5. PubMed ID: 8201480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
    Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
    Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
    Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
    S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.